Psilocybin in “Magic Mushrooms” May Help Treat Depression, Yale Research Shows
Research into a psychedelic drug used recreationally for decades is showing promise in treating both depression and obsessive-compulsive disorder, according to Yale School of Medicine researchers.Source: New Haven Register
Telehealth Social Rhythm Therapy to Reduce Mood Symptoms and Suicide Risk Among Adolescents and Young Adults With Bipolar Disorder
Yale researchers found in a recent study that SRT delivered largely by telemedicine is feasible and acceptable. The intervention appeared to reduce mood symptoms, and suicide propensity independent of mood symptoms, among adolescents and young adults with bipolar disorder.Source: The American Journal of Psychotherapy
Brain games help restore function after mild TBIs, study finds
Morris Bell, PhD, ABPP, Professor Emeritus and Senior Research Scientist in Psychiatry; VA RR&D Senior Research Career Scientist, spoke with Military Times about his recent study that found veterans with a history of mild traumatic brain injury showed vast improvement in cognitive function after 12 weeks using an online brain game program.Source: Military Times
Pilot grants to study the health of women and resources for women faculty at Yale gaining momentum
Even today, attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations at Yale – Women’s Health Research at Yale (WHRY) and the Office of Cooperative Research (OCR) --- are looking to change those trends, offering grants and programs specifically aimed at supporting women’s health research and supporting women faculty who wish to seek funding to bring their discoveries to a commercial light.
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression
Samuel Wilkinson, MD, Assistant Professor of Psychiatry, is co-author of the study, "Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM Studies."Source: Journal of Clinical Psychiatry
Suicide Attempts of Muslims Compared With Other Religious Groups in the US
Hamada Hamid Altalib, DO, MPH, Associate Professor of Neurology and of Psychiatry, is the lead author of a new study comparing the prevalence of suicide attempts among Muslim adults compared with adults of other faith communities in the US. Altalib is part of the Yale Global Mental Health faculty leadership.Source: JAMA Psychiatry
Nyberg: Yale Researchers Studying Impact of Music on People with Psychosis
Adam Christoferson, founder and director of Musical Intervention, and Phil Corlett, PhD, Associate Professor of Psychiatry, talk with WTNH's Ann Nyberg about how Musical Intervention came to be and the work it does for those in recovery, how music bridges the gap, how the pair began their collaboration, and how they are studying the impact of music on people with psychotic illness.Source: WTNH
A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression
While clinical trials have shown meaningful antidepressant effects of ketamine in many patients with treatment-refractory illness, there remains concern that long-term ketamine treatment, especially of high frequency, could have negative health outcomes.Source: The American Journal of Psychiatry
Large Genomic Analysis Highlights COVID-19 Risk Factors
In March 2020, thousands of scientists around the world, including Yale's Renato Polimanti, PhD, MSc, Assistant Professor of Psychiatry; Gita Pathak, PhD, Postdoctoral Associate; and Frank Wendt, PhD, Postdoctoral Fellow, united to answer a pressing and complex question: What genetic factors influence why some COVID-19 patients develop severe, life-threatening disease requiring hospitalization, while others escape with mild symptoms or none at all?
Psychedelic Spurs Growth of Neural Connections Lost in Depression
In a new study, Yale researchers show that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. The findings are published July 5 in the journal Neuron.Source: Yale News
Use and Perceptions of Electronic Nicotine Delivery Systems Among Patients Attending Lung Cancer Screening Who Smoke
Yale researchers, led by first author Lisa Fucito, PhD, Associate Professor of Psychiatry, surveyed patients during lung cancer screenings to understand their use of electronic nicotine delivery products and their beliefs and knowledge of these products. The findings were published in Preventive Medicine Reports.Source: Preventive Medicine Reports
SLEEP-SMART Intervention Shows Promising Results for Women Suffering from Sleeping Problems, Depression, and Anxiety
Preliminary data indicate SLEEP-SMART can improve sleep patterns, show associated reductions in symptoms of depression and anxiety, and improve the functioning of brain circuits important in emotional and cognitive health.
How Your Help Can Fund the Next Discovery in Women's Health Research
If the challenges of the past year have taught us anything, it is that we must continue working to understand all that we can about health and disease. And when it comes to sex and gender, we should not wait for the next crisis before addressing these critical components of our health.
Evaluation of a Behavioral Self-Care Intervention Administered through a Massive Open Online Course
Marney White, PhD, MS, Associate Professor of Public Health and a clinical psychologist at Yale School of Medicine, and colleagues analyzed the results of the first cohort of learners who took a self-care intervention course and found the intervention was effective in reducing stress, anxiety, and depression – even during the COVID crisis. The study was published in American Journal of Health Education.Source: American Journal of Health Education
Yale Study Finds Elevated Suicide Risk for Older Adults Diagnosed With Dementia
Adults over age 65 who have been diagnosed with Alzheimer’s disease or other dementia are more than twice as likely to die from suicide compared to older adults who do not suffer from dementia, according to a new study led by Timothy Schmutte, PsyD, Assistant Professor of Psychiatry
WHRY Funds Studies on Heart Disease, Insomnia, and Pain
Women’s Health Research at Yale today announced funding for three new studies investigating a method for improving the diagnosis of heart disease in women, a therapy for clinically significant sleep disruption common in Black women, and the influence of biological sex on the underlying brain patterns that link pain and opioid use.
Implicit Organizational Bias: Mental Health Treatment Culture and Norms as Barriers to Engaging with Diversity
Miraj Desai, PhD, Instructor in Psychiatry, is first author of a paper in American Psychologist that aimed to better understand the sources of barriers to care for Latinx and Asian patient populations by examining shared themes across providers’ descriptions of their encounters.Source: Race, Research & Policy Portal
Largest Genome Study to Date of Anxiety Reveals New Risk Variants and Suggests Possible Biological Mechanisms
Daniel Levey, PhD, Associate Research Scientist in Psychiatry, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience, are among the authors of a study relating DNA variations and anxiety disorders which has revealed several previously unidentified locations in the human genome where variations in the sequence tend to occur in people with anxiety, compared with people who don't have anxiety.Source: Brain & Behavior Research Foundation
Yale Researchers Size up the Mental Health Toll of the Pandemic
While researchers have known about the mental health costs of chronic stress, they say this situation is unique because during the pandemic people have also lost many of the social connections and outlets needed to help manage their stress loads.Source: YaleNews